Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 15, 2022 - Issue
Submit an article Journal homepage
578
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

Andrew N Menzies-Gow1 UK Severe Asthma Network and National Registry, Royal Brompton & Harefield Hospitals, London, UKView further author information
,
Claire McBrien2 Kingston Hospital, London, UKView further author information
,
Bindhu Unni3 Observational and Pragmatic Research Institute, Singapore, SingaporeView further author information
,
Celeste M Porsbjerg4 Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, DenmarkView further author information
,
Mona Al-Ahmad5 Al-Rashed Allergy Center, Ministry of Health, Microbiology Department, Faculty of Medicine, Kuwait University, Kuwait, KuwaitORCID Iconhttps://orcid.org/0000-0003-2950-5363View further author information
ORCID Icon,
Christopher S Ambrose6 AstraZeneca, Gaithersburg, MD, USAORCID Iconhttps://orcid.org/0000-0003-4175-7336View further author information
ORCID Icon,
Karin Dahl Assing7 Department of Respiratory Medicine, Aalborg University Hospital, Aalborg, DenmarkView further author information
,
Anna von Bülow4 Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, DenmarkView further author information
,
John Busby8 UK Severe Asthma Network and National Registry, Queen’s University Belfast, Belfast, Northern IrelandView further author information
,
Borja G Cosio9 Son Espases University Hospital-IdISBa-Ciberes, Mallorca, SpainORCID Iconhttps://orcid.org/0000-0002-6388-8209View further author information
ORCID Icon,
J Mark FitzGerald10 The Centre for Lung Health, Vancouver Coastal Health Research Institute, UBC, Vancouver, CanadaView further author information
,
Esther Garcia Gil11 AstraZeneca, Barcelona, SpainView further author information
,
Susanne Hansen12 Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, DenmarkView further author information
,
Liam G aHeaney8 UK Severe Asthma Network and National Registry, Queen’s University Belfast, Belfast, Northern IrelandView further author information
,
Mark Hew13 Allergy, Asthma & Clinical Immunology Service, Alfred Health, Melbourne, Australia;14 Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaView further author information
,
David J Jackson15 UK Severe Asthma Network andNational Registry, Guy’s and St Thomas’ NHS Trust, London, UK;16 School of Immunology & Microbial Sciences, King’s College London, London, UKView further author information
,
Maria Kallieri17 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, GreeceView further author information
,
Stelios Loukides17 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, GreeceORCID Iconhttps://orcid.org/0000-0002-4278-9922View further author information
ORCID Icon,
Njira L Lugogo18 Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USAView further author information
,
Andriana I Papaioannou17 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, GreeceORCID Iconhttps://orcid.org/0000-0001-9708-3241View further author information
ORCID Icon,
Désirée Larenas-Linnemann19 Directora Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Ciudad de México, MexicoORCID Iconhttps://orcid.org/0000-0002-5713-5331View further author information
ORCID Icon,
Wendy C Moore20 Pulmonary, Critical Care, Allergy, and Immunologic Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
,
Luis A Perez-de-Llano21 Department of Respiratory Medicine, Hospital Universitario Lucus Augusti, Lugo, SpainORCID Iconhttps://orcid.org/0000-0003-2652-6847View further author information
ORCID Icon,
Linda M Rasmussen22 Allergy Clinic, Department of Dermato-Allergology, Gentofte Hospital, Copenhagen, DenmarkView further author information
,
Johannes M Schmid23 University Hospital of Aarhus, Aarhus, DenmarkView further author information
,
Salman Siddiqui24 University of Leicester, Department of Respiratory Sciences & NIHR Leicester Biomedical Research Centre (Respiratory Theme), Leicester, UKView further author information
,
Marianna Alacqua25 AstraZeneca, Cambridge, UKView further author information
,
Trung N Tran6 AstraZeneca, Gaithersburg, MD, USAView further author information
,
Charlotte Suppli Ulrik26 Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, Hvidovre, DenmarkORCID Iconhttps://orcid.org/0000-0001-8689-3695View further author information
ORCID Icon,
John W Upham27 Diamantina Institute & PA-Southside Clinical Unit, The University of Queensland, Brisbane, AustraliaView further author information
,
Eileen Wang28 Division of Allergy & Clinical Immunology, Department of Medicine, National Jewish Health, Denver, CO, USA;29 Division of Allergy & Clinical Immunology, Department of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USAView further author information
,
Lakmini Bulathsinhala3 Observational and Pragmatic Research Institute, Singapore, Singapore;30 Optimum Patient Care, Cambridge, UKView further author information
,
Victoria A Carter3 Observational and Pragmatic Research Institute, Singapore, Singapore;30 Optimum Patient Care, Cambridge, UKView further author information
,
Isha Chaudhry3 Observational and Pragmatic Research Institute, Singapore, Singapore;30 Optimum Patient Care, Cambridge, UKView further author information
,
Neva Eleangovan3 Observational and Pragmatic Research Institute, Singapore, Singapore;30 Optimum Patient Care, Cambridge, UKView further author information
,
Ruth B Murray3 Observational and Pragmatic Research Institute, Singapore, Singapore;30 Optimum Patient Care, Cambridge, UKView further author information
,
Chris A Price3 Observational and Pragmatic Research Institute, Singapore, Singapore;30 Optimum Patient Care, Cambridge, UKView further author information
&
David B Price3 Observational and Pragmatic Research Institute, Singapore, Singapore;30 Optimum Patient Care, Cambridge, UK;31 Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9728-9992View further author information
ORCID Icon show all
Pages 63-78 | Published online: 13 Jan 2022

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jaskiran K Khosa, Samuel Louie, Pamela Lobo Moreno, Dmitry Abramov, Daniel K Rogstad, Abdullah Alismail, Michael J Matus & Laren D Tan. (2023) Asthma Care in the Elderly: Practical Guidance and Challenges for Clinical Management - A Framework of 5 “Ps”. Journal of Asthma and Allergy 16, pages 33-43.
Read now
Yen Chung, Diego J. Maselli, Fan Mu, Erin E. Cook, Danni Yang, Joshua A. Young, Keith A. Betts, Eduardo Genofre & Donna Carstens. (2023) Impact of benralizumab on asthma exacerbation-related medical healthcare resource utilization and medical costs: results from the ZEPHYR 2 study. Journal of Medical Economics 26:1, pages 954-962.
Read now
Joseph L. Smith, Yen Chung, John Barron, Theodore Barlows, Bal Nepal & Donna Carstens. (2023) Exacerbations, treatment patterns, utilization, and costs before and after initiating of benralizumab for the treatment of severe eosinophilic asthma. Journal of Asthma 0:0, pages 1-12.
Read now
Josje Otten, Rik van der Lans, Eugenio de Corso, kanstantsin Dziadziulia, Bart Hilvering, Els Weersink, Matteo Bonini, Jan Hagemann, Wanrawee Thaitrakool, Claudio Montuori, Ludger Klimek, Sietze Reitsma & Wytske Fokkens. (2023) Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making. Expert Review of Clinical Immunology 19:8, pages 1041-1049.
Read now

Articles from other publishers (19)

Wenjia Chen, Trung N. Tran, Mohsen Sadatsafavi, Ruth Murray, Nigel Chong Boon Wong, Nasloon Ali, Con Ariti, Lakmini Bulathsinhala, Esther Garcia Gil, J. Mark FitzGerald, Marianna Alacqua, Mona Al-Ahmad, Alan Altraja, Riyad Al-Lehebi, Mohit Bhutani, Leif Bjermer, Anne-Sofie Bjerrum, Arnaud Bourdin, Anna von Bülow, John Busby, Giorgio Walter Canonica, Victoria Carter, George C. Christoff, Borja G. Cosio, Richard W. Costello, João A. Fonseca, Peter G. Gibson, Kwang-Ha Yoo, Liam G. Heaney, Enrico Heffler, Mark Hew, Ole Hilberg, Flavia Hoyte, Takashi Iwanaga, David J. Jackson, Rupert C. Jones, Mariko Siyue Koh, Piotr Kuna, Désirée Larenas-Linnemann, Sverre Lehmann, Lauri Lehtimäki, Juntao Lyu, Bassam Mahboub, Jorge Maspero, Andrew N. Menzies-Gow, Anthony Newell, Concetta Sirena, Nikolaos G. Papadopoulos, Andriana I. Papaioannou, Luis Perez-de-Llano, Diahn-Warng Perng (Steve)Matthew Peters, Paul E. Pfeffer, Celeste M. Porsbjerg, Todor A. Popov, Chin Kook Rhee, Sundeep Salvi, Camille Taillé, Christian Taube, Carlos A. Torres-Duque, Charlotte Ulrik, Seung-Won Ra, Eileen Wang, Michael E. Wechsler & David B. Price. (2023) Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry. The Journal of Allergy and Clinical Immunology: In Practice 11:9, pages 2732-2747.
Crossref
Peer Ameen Shah & Chris Brightling. (2023) Biologics for severe asthma—Which, when and why?. Respirology 28:8, pages 709-721.
Crossref
Paul E. Pfeffer, Nasloon Ali, Ruth Murray, Charlotte Ulrik, Trung N. Tran, Jorge Maspero, Matthew Peters, George C. Christoff, Mohsen Sadatsafavi, Carlos A. Torres‐Duque, Alan Altraja, Lauri Lehtimäki, Nikolaos G. Papadopoulos, Sundeep Salvi, Richard W. Costello, Breda Cushen, Enrico Heffler, Takashi Iwanaga, Mona Al‐Ahmad, Désirée Larenas‐Linnemann, Piotr Kuna, João A. Fonseca, Riyad Al‐Lehebi, Chin Kook Rhee, Luis Perez‐de‐Llano, Diahn‐Warng Perng Steve, Bassam Mahboub, Eileen Wang, Celine Goh, Juntao Lyu, Anthony Newell, Marianna Alacqua, Andrey S. Belevskiy, Mohit Bhutani, Leif Bjermer, Unnur Bjornsdottir, Arnaud Bourdin, Anna von Bulow, John Busby, Giorgio Walter Canonica, Borja G. Cosio, Delbert R. Dorscheid, Mariana Muñoz‐Esquerre, J. Mark FitzGerald, Esther Garcia Gil, Peter G. Gibson, Liam G. Heaney, Mark Hew, Ole Hilberg, Flavia Hoyte, David J. Jackson, Mariko Siyue Koh, Hsin‐Kuo Bruce Ko, Jae Ha Lee, Sverre Lehmann, Cláudia Chaves Loureiro, Dóra Lúðvíksdóttir, Andrew N. Menzies‐Gow, Patrick Mitchell, Andriana I. Papaioannou, Todor A. Popov, Celeste M. Porsbjerg, Laila Salameh, Concetta Sirena, Camille Taillé, Christian Taube, Yuji Tohda, Michael E. Wechsler & David B. Price. (2023) Comparative effectiveness of anti‐IL5 and anti‐IgE biologic classes in patients with severe asthma eligible for both . Allergy 78:7, pages 1934-1948.
Crossref
Francisco Casas-Maldonado, Francisco-Javier Álvarez-Gutiérrez, Marina Blanco Aparicio, Christian Domingo Ribas, Carolina Cisneros Serrano, Gregorio Soto Campos, Berta Román Bernal & Francisco-Javier González-Barcala. (2023) Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain. Open Respiratory Archives 5:3, pages 100252.
Crossref
Donna Carstens, Diego J. Maselli, Fan Mu, Erin E. Cook, Danni Yang, Joshua A. Young, Keith A. Betts, Eduardo Genofre & Yen Chung. (2023) Real-World Effectiveness Study of Benralizumab for Severe Eosinophilic Asthma: ZEPHYR 2. The Journal of Allergy and Clinical Immunology: In Practice 11:7, pages 2150-2161.e4.
Crossref
Giulia Scioscia, Santi Nolasco, Raffaele Campisi, Carla Maria Irene Quarato, Cristiano Caruso, Corrado Pelaia, Andrea Portacci & Claudia Crimi. (2023) Switching Biological Therapies in Severe Asthma. International Journal of Molecular Sciences 24:11, pages 9563.
Crossref
Alain Didier & Laurent Guilleminault. (2023) Quelle biothérapie choisir en fonction des caractéristiques de l’asthme sévère chez l’adulte ?. Bulletin de l'Académie Nationale de Médecine 207:5, pages 612-618.
Crossref
Ayobami Akenroye, Guohai Zhou, John W. Jackson, Jodi Segal, G. Caleb Alexander & Sonal Singh. (2022) Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. Allergy 78:4, pages 1116-1119.
Crossref
Matteo Maule, Bianca Olivieri, Gabriella Guarnieri, Lucia De Franceschi, Nicola Martinelli, Rachele Vaia, Giuseppe Argentino, Andrea Vianello, Gianenrico Senna & Marco Caminati. (2023) Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach. Journal of Clinical Medicine 12:6, pages 2294.
Crossref
Youngsoo Lee, Ji-Hyang Lee, So Young Park, Ji-Ho Lee, Joo-Hee Kim, Hyun Jung Kim, Sang-Heon Kim, Kian Fan Chung & Woo-Jung Song. (2023) Roles of real-world evidence in severe asthma treatment: challenges and opportunities. ERJ Open Research 9:2, pages 00248-2022.
Crossref
Hiroyuki Nagase, Maho Suzukawa, Keiji Oishi & Kazuto Matsunaga. (2023) Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy. Allergology International 72:1, pages 11-23.
Crossref
John Politis & Philip G. Bardin. (2022) Switching Biological Therapies in Adults with Severe Asthma: What Are the Dilemmas and Is It Worthwhile?. Annals of the American Thoracic Society 19:12, pages 1965-1970.
Crossref
Xinni Xu, Sietze Reitsma, De Yun Wang & Wytske J. Fokkens. (2022) Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID ‐exacerbated respiratory disease . Allergy 77:12, pages 3593-3605.
Crossref
David Price & Arnaud Bourdin. (2022) Proactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care. EMJ Respiratory.
Crossref
Francesco Menzella, Andrea Ballarin, Maria Sartor, Ariel Fabian Floriani, Lorenzo Corsi, Cristina Dartora, Silvia Tonin & Micaela Romagnoli. (2022) Comparison between clinical trials and real-world evidence studies on biologics for severe asthma. Journal of International Medical Research 50:11, pages 030006052211336.
Crossref
Muhammad Adrish & Nicola A. Hanania. (2022) Choosing and switching biological agents in severe asthma. Respirology 27:11, pages 926-928.
Crossref
Anne-Noelle Frix, Liam G. Heaney, Barbro Dahlén, Florin Mihaltan, Svetlana Sergejeva, Sanja Popović-Grle, Vratislav Sedlak, Lauri Lehtimäki, Arnaud Bourdin, Stephanie Korn, Eleftherios Zervas, Zsuzsanna Csoma, Dora Lúðvíksdóttir, Marcus Butler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Anneke Ten Brinke, Piotr Kuna, Claudia Chaves Loureiro, Natalia M. Nenasheva, Zorica Lazic, Sabina Škrgat, David Ramos-Barbon, Joerg Leuppi, Bilun Gemicioglu, Apostolos Bossios, Celeste M. Porsbjerg, Elisabeth H. Bel, Ratko Djukanovic & Renaud Louis. (2022) Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study. ERJ Open Research 8:4, pages 00273-2022.
Crossref
María Isabel Delgado Dolset, David Obeso, Juan Rodriguez-Coira, Alma Villaseñor, Heleia González Cuervo, Ana Arjona, Coral Barbas, Domingo Barber, Teresa Carrillo & María M. Escribese. (2022) Contribution of allergy in the acquisition of uncontrolled severe asthma. Frontiers in Medicine 9.
Crossref
Jeffrey Shi Kai Chan, Ruth B. Murray & David Price. (2022) Oral corticosteroids in asthma and beyond: moving forward. European Respiratory Journal 60:3, pages 2200776.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.